aSource: Centers for Disease Control and Prevention (CDC), National Immunization Program. State-level data based on self-reports by the states submitted to CDC in August 1999, estimating state-level expenditures for the year 2000.
bIncludes $261 million in Financial Assistance and $10 million in Direct Assistance; also includes carryover funds as well as new awards.
cThis figure is likely to increase when new recommendations of the Advisory Committee on Immunization Practices are incorporated into the vaccine schedule. For example, the pneumococcal conjugate vaccine was approved in February 2000 for all infants<2 years of age and for high-risk children<5 years of age.
dState report data include funds from multiple sources, including state revenues and in-kind support, local funds, other federal funds applied to immunization efforts (e.g., Title V, Preventive Health Services Block Grants), and private funds.